Timing and expression of the angiopoietin-1-Tie-2 pathway in murine lung development and congenital diaphragmatic hernia
Related Experiment Video
Updated: May 19, 2026

Implantation of Fibrin Gel on Mouse Lung to Study Lung-specific Angiogenesis
Published on: December 21, 2014
Adrienne Grzenda1, John Shannon, Jason Fisher
1Charles Edison Laboratory for Pediatric Surgery Research, Department of Surgery, Division of Pediatric Surgery, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA.
Insights
Congenital diaphragmatic hernia (CDH) causes lung and pulmonary hypertension issues. This study shows Angiopoietin-1 (Ang-1) pathway alterations may drive pulmonary vasculopathy in CDH.
Area of Science:
- Developmental biology
- Cardiovascular research
- Pediatric medicine
Background:
- Congenital diaphragmatic hernia (CDH) is a common birth defect causing severe respiratory insufficiency.
- Pulmonary hypertension is a critical comorbidity in CDH, linked to mortality, but its molecular basis is unclear.
- Angiopoietin-1 (Ang-1) is vital for vascular development, but its role in CDH-associated pulmonary hypertension is unknown.
Purpose of the Study:
- To investigate the role of the Angiopoietin-1 (Ang-1) pathway in the development of pulmonary hypertension in a murine model of congenital diaphragmatic hernia (CDH).
Main Methods:
- Established a nitrofen and bisdiamine-induced murine model of CDH.
- Analyzed tissue-level expression and localization patterns of Ang-1 during normal lung development.
- Examined expression of Ang-1, its receptor Tie-2, and transcription factor Ets-1 in the CDH model.
Main Results:
- Angiopoietin-1 (Ang-1) is crucial for normal murine lung development, with defined expression patterns.
- The study identified altered expression of Ang-1, Tie-2, and Ets-1 in the CDH model.
- These alterations suggest a role in the pulmonary vasculopathy observed in congenital diaphragmatic hernia.
Conclusions:
- The Angiopoietin-1 (Ang-1) pathway is implicated in normal lung development.
- Aberrant Ang-1 pathway signaling contributes to pulmonary vasculopathy in congenital diaphragmatic hernia (CDH).
- Targeting the Ang-1 pathway may offer therapeutic strategies for CDH-related pulmonary hypertension.
Abstract:
Congenital diaphragmatic hernia (CDH) is one of the most common congenital abnormalities. Children born with CDH suffer a number of co-morbidities, the most serious of which is respiratory insufficiency from a combination of alveolar hypoplasia and pulmonary vascular hypertension. All children born with CDH display some degree of pulmonary hypertension, the severity of which has been correlated with mortality. The molecular mechanisms responsible for the development of pulmonary hypertension in CDH remain poorly understood. Angiopoitein-1 (Ang-1), a central mediator in angiogenesis, participates in the vascular development of many tissues, including the lung. Although previous studies have demonstrated that Ang-1 might play an important role in the development of familial pulmonary hypertension, the role of Ang-1 in the development of the pulmonary hypertension associated with CDH is poorly understood. The aim of this study was to examine the role of the Ang-1 pathway in a murine model of CDH. Here, we report that Ang-1 appears important in normal murine lung development, and have established its tissue-level expression and localization patterns at key time-points. Additionally, our data from a nitrofen and bisdiamine-induced murine model of CDH suggests that altered expression patterns of Ang-1, its receptor Tie-2 and one of its transcription factors (epithelium-specific Ets transcription factor 1) might be responsible for development of the pulmonary vasculopathy seen in the setting of CDH.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
Mechanism of Angiogenesis

